ProfileGDS5678 / 1437780_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 65% 64% 63% 63% 62% 64% 63% 63% 63% 61% 63% 62% 63% 69% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.943265
GSM967853U87-EV human glioblastoma xenograft - Control 23.7986464
GSM967854U87-EV human glioblastoma xenograft - Control 33.7913363
GSM967855U87-EV human glioblastoma xenograft - Control 43.7531363
GSM967856U87-EV human glioblastoma xenograft - Control 53.6511562
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.8974764
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.8521263
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.7746163
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.7613563
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.643161
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.7866563
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.6714362
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.7850363
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 54.2584269